e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oral presentation: New insights and therapeutically strategies for emphysema and COPD: the growth factors KGF and TGF?-1
A. Ö. Yildirim, M. Vandana, G. John, B. Müller, H. Fehrenbach (Borstel, Germany)
Source:
Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Number:
5
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ö. Yildirim, M. Vandana, G. John, B. Müller, H. Fehrenbach (Borstel, Germany). Oral presentation: New insights and therapeutically strategies for emphysema and COPD: the growth factors KGF and TGF?-1. Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
LSC 2010 Abstract: New insights and therapeutically strategies for emphysema and COPD: The growth factors KGF and TGFβ-1
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
Source: Eur Respir J 2014; 44: 513-522
Year: 2014
Airway inflammation in asthma: current and future targets and therapies
Source: Breathe 2010; 6: 245-252
Year: 2010
Translating mechanisms to new drugs for COPD exacerbations
Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Year: 2009
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007
New aspects of COPD ethiopathogenesis
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept